Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex

Experimental Neurology

Volumn 123, Issue 2, 1993, Pages 204-215

  Fix, Andrew S ^a   Horn, Jeffrey W ^a   Wightman, Karen A ^a   Johnson, Charles A ^a   Long, Gerald G ^a   Storts, Ralph W ^b   Farber, Nuri ^c   Wozniak, David F ^c   Olney, John W ^c  

^a ELI LILLY AND COMPANY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0027521274     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1993.1153     Document Type: Article

References (29)

1. Allen, H. L., and L. L. Iversen. 1990. Phencyclidine, dizocil-pine, and cerebrocortical neurons. Science 247: 221.
2. Anderson, T. D., R. Arceo, Z. Rüben, and D. Feldman. 1992. Détection and confirmation of neuronal necrosis in toxicity studies. Vet. Pathoi 29: 465. [Abstract].
3. Arceo, R., L. Kaufman, D. Feldman, Z. Rüben, and T. D. Anderson. 1993. A time sequence study of neuronal vacuoles induced by dextrorphan hydrochloride (DH) in the rat: Light and electrón microscopic observations. Toxicol. Pathoi. 21: in press.
4. Choi, D. W. 1992. Bench to bedside: The glutamate connec tion. Science 258: 241-243.
5. Clifford, D. B., C. F. Zorumski, and J. W. Olney. 1989. Keta-mine and MK 801 prevent degeneration of thalamic neurons induced by focal cortical seizures. Exp. Neurol, 105: 272-279.
6. Clineschmidt, B. V., G. E. Martin, P. R. Bunting, and N. L. Papp. 1992. Central sympathomimetic activity of (+)-5-methyl-10, ll-5H-dibenzo[a, d]cyclohepten-5, 10-imine (MK801), a substance with potent anticonvuisant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev, Res. 2: 135-145.
7. Duchen, L. W. 1984. General pathoiogy of neurons and neuro-glia. In Greenfield's Neuropathology (J. H. Adams, J. A. N. Cor-sellis, and L. W. Duchen, Eds.), pp. 1-52. John Wiley and Sons, New York.
8. Färber, N. B., M. T. Price, J. Labruyere, T. A. Füller and J. W. Olney. 1993. Age dependency of NMDA antagonist neurotoxicity. Soc. Neurosci. Abstr. 18: 1148.
9. Fix, A. S., K. A. Wightman, C. A. Johnson, L. Truex, R. Smith, E. Gomez, G. G. Long, and R. W. Storts. 1992. Dose-dependent neuronal degeneration induced by the NMDA antagonist MK{+)801 in the rat cerebral cortex. Vet. PathoL 29; 447. [Abstract].
10. Foster, A. C., and E. H. F. Wong. 1987. The novel anticonvul-sant MK-801 binds to the activated state of the iV-methyl-Daspartate receptor in rat brain. Br. J. Pharmacol. 91: 403-409.
11. Gill, R., A. C. Foster, and G. N. Woodruff. 1988. MK-801 is neuroprotective in gerbils when administered during the post-ischemic period. Neuroscience 25: 847-855.
12. Huettner, J. E., and B. P. Bean. 1988. Block of iV-methyl-D-aspartate-activated current by the anticonvuisant MK-801: Selective bin din g to open channels. Proc. Natl. Acad. Sei. USA 85: 1307-1311.
13. Labruyere, J., M. T. Price, and J. W. Olney. 1989. NMDA antagonista induce pathomorphologicâl changes in cerebrocorti-cal neurons. Soc. Neurosci. Abstr. 15: 761. [Abstract].
14. Lawlor, B. A., and K. L. Davis. 1992. Does modulation of glu-taminergic function represent a viable therapeutic strategy in Alzheimer's disease? Biol. Psychiatry 31: 337-350.
15. Lipton, S. A. 1992. Models of neuronal injury in AIDS: Another role for the NMDA receptor? Trends Neurosci. 15: 75-79.
16. Mcculloch, J. 1991. Ischemic brain disease-prevention with compétitive and non-competitive antagonists of ÀT-methyl-D-aspartate receptors. Drug Res. 41: 319-324.
17. Mcculloch, J., and L. L. Iversen. 1991. Autoradiographic as-sessment of the effects of iV-methyl-D-asparate receptor antagonists in vivo. Neurochem. Res. 16: 951-963.
18. Monaghan, D. T., R. J. Bridges, and C. W. Cotman. 1989. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29: 365-402.
19. Olney, J. W, 1982. The toxic effects of glutamate and related compounds irv the retina and brain. Retina 2: 341-359.
20. Olney, J. W. 1989. Excitotoxicity and iV-methyl-D-aspartate receptors. Drug Dev. Res. 17: 299-319.
21. Olney, J. W., J. Labruyere, and M. T. Price. 1989. Pathologi-cal changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1360-1362.
22. Olney, J. W., J. Labruyere, G. Wang, D. F. Wozniak, M. T. Price, and M. A. Sesma. 1991. NMDA antagonist neurotoxicity: Mechanism and prévention. Science 254: 1515-1518.
23. Olney, J. W., M. T. Price, K. S. Salles, J. Labruyere, and G. Frierdich. 1987. MK-801 powerfully protects against N-methyl asp arta te neurotoxicity. Eur. J. Pharmacol. 141: 357-361.
24. Paxinos, G., and C. Watson. 1986. The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, San Diego.
25. Rothman, S. M., and J. W. Olney. 1986. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19: 105-111.
26. Sesma, M. A., M. T. Price, and J. W. Olney. 1991. Heat shock protein (HSP72) response to NMDA antagonists is blocked by anticholinergics or gabamimetics. Soc. Neurosci. Abstr. 17: 254.
27. Sharp, F. R., P. Jasper, J. Hall, L. Noble, and S. Sagar. 1991. MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann. Neurol. 30: 801-809.
28. Sharp, F. R., M. Butman, S. Wang, J. Koistinaho, S. H. Graham, S. M. Sagar, L. Noble, P. Berger, and F. M. Longo. 1992. Haloperidol prevenís induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine. J. Neurosci. Res. 33: 605-616.
29. Wong, E. F., J. A. Kemp, T. Priestley, A. R. Knight, G. N. Woodruff, and L. L. Iversen. 1986. The anticonvuisant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sel USA 83: 7104-7108.